Association of FSAP Marburg I with VTE
. | No. . | Carriers of FSAP Marburg I, no. (%) . | Comparison vs controls I, odds ratio (95% CI) . | Comparison vs controls II, odds ratio (95% CI) . |
---|---|---|---|---|
Idiopathic VTE | 103 | 12 (11.7) | 5.5 (1.9,16.0)†* | 2.7 (1.2,6.1)‡ |
Secondary VTE | 110 | 5 (4.5) | 2.0 (0.56,7.0)* | 0.99 (0.35,2.8) |
VTE | 213 | 17 (8.0) | 3.6 (1.3,10.0)*‡ | 1.8 (0.88,3.7) |
Controls I | 213 | 5 (2.3) | NA | NA |
Controls II | 327 | 15 (4.6) | NA | NA |
. | No. . | Carriers of FSAP Marburg I, no. (%) . | Comparison vs controls I, odds ratio (95% CI) . | Comparison vs controls II, odds ratio (95% CI) . |
---|---|---|---|---|
Idiopathic VTE | 103 | 12 (11.7) | 5.5 (1.9,16.0)†* | 2.7 (1.2,6.1)‡ |
Secondary VTE | 110 | 5 (4.5) | 2.0 (0.56,7.0)* | 0.99 (0.35,2.8) |
VTE | 213 | 17 (8.0) | 3.6 (1.3,10.0)*‡ | 1.8 (0.88,3.7) |
Controls I | 213 | 5 (2.3) | NA | NA |
Controls II | 327 | 15 (4.6) | NA | NA |
Controls I indicates healthy blood donors; controls II, non-VTE patients; and NA, not applicable.
The data presented here (univariate analyses) differ slightly from those of our initial report (logistic regression analyses; independent variables: factor V Leiden, prothrombin 20210G→A, and FSAP Marburg I).1
P = .001 (Fisher exact test).
P < .05 (Fisher exact test).